Greedy Insider · Filing
COCP · 13D amendment · OPKO HEALTH, INC. and affiliates
OPKO HEALTH, INC. and affiliates reported a 29.6% stake in Cocrystal Pharma, Inc. (COCP) in a Schedule 13D amendment filed on Nov 6, 2026, triggered by an event on Nov 4, 2026.
Describes filing structure, not future returns. Not investment advice.
Primary source: SEC EDGAR · Accession 0000944809-26-000003